| Renal Carcinomas With the t (6; 11)(p21; q12): Clinicopathologic Features and Demonstration of the Specific: Alpha-TFEB: Gene Fusion by Immunohistochemistry, RT-PCR, and DNA PCR P Argani, M Laé, B Hutchinson, VE Reuter, MH Collins, J Perentesis, ... The American journal of surgical pathology 29 (2), 230-240, 2005 | 322 | 2005 |
| Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971 AS Gamis, TA Alonzo, RB Gerbing, JM Hilden, AD Sorrell, M Sharma, ... Blood, The Journal of the American Society of Hematology 118 (26), 6752-6759, 2011 | 243 | 2011 |
| Management of metabolic effects associated with anticancer agents targeting the PI3K-Akt-mTOR pathway NL Busaidy, A Farooki, A Dowlati, JP Perentesis, JE Dancey, LA Doyle, ... Journal of Clinical Oncology 30 (23), 2919, 2012 | 221 | 2012 |
| Glutathione S-Transferase Polymorphisms and Outcome of Chemotherapy in Childhood Acute Myeloid Leukemia SM Davies, LL Robison, JD Buckley, T Tjoa, WG Woods, GA Radloff, ... Journal of clinical oncology 19 (5), 1279-1287, 2001 | 177 | 2001 |
| Glutathione S-transferase genotypes, genetic susceptibility, and outcome of therapy in childhood acute lymphoblastic leukemia SM Davies, S Bhatia, JA Ross, WR Kiffmeyer, PS Gaynon, GA Radloff, ... Blood, The Journal of the American Society of Hematology 100 (1), 67-71, 2002 | 156 | 2002 |
| Sirolimus for progressive neurofibromatosis type 1–associated plexiform neurofibromas: a Neurofibromatosis Clinical Trials Consortium phase II study B Weiss, BC Widemann, P Wolters, E Dombi, A Vinks, A Cantor, ... Neuro-oncology 17 (4), 596-603, 2015 | 153 | 2015 |
| Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors G Johansson, YY Mahller, MH Collins, MO Kim, T Nobukuni, J Perentesis, ... Molecular cancer therapeutics 7 (5), 1237-1245, 2008 | 149 | 2008 |
| Big babies and infant leukemia: a role for insulin-like growth factor-1? JA Ross, JP Perentesis, LL Robison, SM Davies Cancer Causes & Control 7, 553-559, 1996 | 146 | 1996 |
| Ethnicity and survival in childhood acute myeloid leukemia: a report from the Children's Oncology Group R Aplenc, TA Alonzo, RB Gerbing, FO Smith, S Meshinchi, JA Ross, ... Blood 108 (1), 74-80, 2006 | 145 | 2006 |
| RAS oncogene mutations and outcome of therapy for childhood acute lymphoblastic leukemia JP Perentesis, S Bhatia, E Boyle, Y Shao, XO Shu, M Steinbuch, ... Leukemia 18 (4), 685-692, 2004 | 139 | 2004 |
| FLASH proton pencil beam scanning irradiation minimizes radiation-induced leg contracture and skin toxicity in mice S Cunningham, S McCauley, K Vairamani, J Speth, S Girdhani, E Abel, ... Cancers 13 (5), 1012, 2021 | 126 | 2021 |
| Glutathione S-Transferase Polymorphisms in Children with Myeloid Leukemia: A Children’s Cancer Group Study SM Davies, LL Robison, JD Buckley, GA Radloff, JA Ross, JP Perentesis Cancer Epidemiology Biomarkers & Prevention 9 (6), 563-566, 2000 | 122 | 2000 |
| Proton FLASH radiotherapy for the treatment of symptomatic bone metastases: the FAST-01 nonrandomized trial AE Mascia, EC Daugherty, Y Zhang, E Lee, Z Xiao, M Sertorio, J Woo, ... JAMA oncology 9 (1), 62-69, 2023 | 118 | 2023 |
| Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with … BC Widemann, E Dombi, A Gillespie, PL Wolters, J Belasco, S Goldman, ... Neuro-oncology 16 (5), 707-718, 2014 | 118 | 2014 |
| Children's Oncology Group's 2013 blueprint for research: acute myeloid leukemia AS Gamis, TA Alonzo, JP Perentesis, S Meshinchi, ... Pediatric blood & cancer 60 (6), 964-971, 2013 | 114 | 2013 |
| Increasing the efficiency of trial-patient matching: automated clinical trial eligibility pre-screening for pediatric oncology patients Y Ni, J Wright, J Perentesis, T Lingren, L Deleger, M Kaiser, I Kohane, ... BMC medical informatics and decision making 15, 1-10, 2015 | 106 | 2015 |
| Biphenotypic leukemia: immunologic and morphologic evidence for a common lymphoid-myeloid progenitor in humans J Perentesis, NKC Ramsay, R Brunning, JH Kersey, AH Filipovich The Journal of Pediatrics 102 (1), 63-67, 1983 | 103 | 1983 |
| Saccharomyces cerevisiae elongation factor 2. Genetic cloning, characterization of expression, and G-domain modeling. JP Perentesis, LD Phan, WB Gleason, DC LaPorte, DM Livingston, ... Journal of Biological Chemistry 267 (2), 1190-1197, 1992 | 97 | 1992 |
| Sirolimus for non‐progressive NF1‐associated plexiform neurofibromas: an NF clinical trials consortium phase II study B Weiss, BC Widemann, P Wolters, E Dombi, AA Vinks, A Cantor, B Korf, ... Pediatric blood & cancer 61 (6), 982-986, 2014 | 93 | 2014 |
| Differences in outcomes of newly diagnosed acute myeloid leukemia for adolescent/young adult and younger patients: a report from the Children's Oncology Group J Canner, TA Alonzo, J Franklin, DR Freyer, A Gamis, RB Gerbing, ... Cancer 119 (23), 4162-4169, 2013 | 88 | 2013 |
